ニュース
With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out ...
Pharmaceutical manufacturing giant Eli Lilly and Co. is exploring potential economic incentives for a $5.9B biomanufacturing ...
Pharma giant Eli Lilly is planning a $5.9 billion investment for a massive pharmaceutical manufacturing facility in McCord ...
Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...
Pharma giant Eli Lilly may plant a $5.9 billion manufacturing facility in Houston’s Generation Park, bringing serious biotech ...
Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, ...
12 日on MSN
The investment over the next eight years could be the largest ever industry-academic agreement of its kind in the U.S., the ...
For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...
Manufacturers have lined up to announce expansions even as Trump trade policy led to disappointing Q1 results and predictions ...
Continue » Should you invest $1,000 in Eli Lilly right now? Before you buy stock in Eli Lilly, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the ...
Eli Lilly’s stock attracted a flurry of attention this week as traders dove into a pool of call options like it was Black Friday at the options mall. With 57,514 calls traded—up 26% from the ...
Eli Lilly has proposed investing $5.9 billion to build a pharmaceutical facility in Houston's Generation Park.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する